9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in 9 Meters Biopharma, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +7 vs. Q2 2021
- Shares held
- 72.6M
- −1.75M (−2.4%) vs. Q2 2021
- Total value
- $94.2M
- +$12.4M (+15.2%) vs. Q2 2021
- New holders
- 18
- 28 more added
- Sold out
- 11
- 21 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $6.43K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 6 | $22.7K |
| Q2 2023 | 34 | $2.08M |
| Q1 2023 | 39 | $4.45M |
| Q4 2022 | 42 | $3.02M |
| Q3 2022 | 74 | $10.4M |
| Q2 2022 | 88 | $15.2M |
| Q1 2022 | 101 | $45.2M |
| Q4 2021 | 104 | $76.8M |
| Q3 2021 | 105 | $94.2M |
| Q2 2021 | 99 | $81.8M |
| Q1 2021 | 90 | $88.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding 9 Meters Biopharma, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 8,565,974 | $11.1M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 11,669,668 | $15.2M | 0.00% | +743,781+6.8% | Added |
| BlackRock Inc. | 13,566,265 | $17.6M | 0.00% | +81,728+0.6% | Added |
| Adage Capital Partners GP, L.L.C. | 15,000,000 | $19.5M | 0.04% | 00.0% | Unchanged |
| IFP Advisors, Inc | 20 | – | – | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,305,027−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −813,188−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −274,665−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −208,581−100.0% | Sold out |
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,457−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −12,813−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,685−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Rollins Financial | – | – | – | – | Not filed |